Advanced Technologies & Treatments for Diabetes

20th International Conference on Advanced Technologies & Treatments for Diabetes (#ATTD2027). 3-6 March 2027 in Paris, France.

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

👉With just 6 days left until the abstract submission deadline, now is the time to showcase your research and join the scientific program at ATTD-ASIA 2026.

📅Submit by 15 July 2026
🔗https://t.co/Uz6xXZ42lA

#ATTDASIA26 #DiabetesTechnology #DiabetesCare

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

📢We're excited to introduce the ATTD Global Platform - the new digital home for the #ATTD community.

Whether you're looking for upcoming events, educational opportunities or the latest news, you'll find it all in one digital hub.

🌐https://t.co/ur4FZvmmh6

#Diabetes

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

📝Your research could open new conversations, connect you with experts in the field & help advance diabetes care.

Submit your abstract for #ATTD2027 and present your work.

📅Deadline: 9 September
🔗https://t.co/XUhaCmR6ny

#DiabetesResearch #DiabetesTechnology

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Join the next #ATTDJournalClub as Dr. Laya Ekhlaspour presents new research on inhaled Technosphere insulin in youth living with #T1D, followed by a Q&A moderated by Dr. Michael Haller.

📅23 July | 16:00 CEST
👉SIGN UP: https://t.co/otMWZcr47u

Supported by MannKind Corporation.

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

🎙️ #ATTDDiabetesTalks: Insulin in Practice
Episode 7️⃣: "Overcoming Barriers to Insulin Adherence"

🎧 Listen on Spotify: https://t.co/jRBCCXQc9o
🎧 Listen on Apple Podcasts: https://t.co/E7Bjwv1OMk

This series is supported by #Sanofi.

#ATTDEducation #ATTDonUNLOK #UNLOKEducation

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

📢Good news!

We've extended the abstract submission deadline for #ATTDASIA26 to 15 July 2026.

Share your latest findings and contribute to the conversations!
🔗Submit your abstract: https://t.co/Uz6xXZ42lA

#DiabetesTechnology #DiabetesCare

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

📢New international guidance is available for the use of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists in people with Type 1 Diabetes.

Endorsed by #ATTD and several leading diabetes organizations

📖Read the guidance: https://t.co/Yh1tSpd7Kj

#Type1Diabetes #GLP1

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Are you presenting, attending, or planning to submit an abstract for #ATTD2027?

Download our Promotional Toolkit and access social media covers and other materials to help spread the word.
📥https://t.co/1GSDRc9vlT

#DiabetesTechnology #DiabetesResearch

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

🤔 Could improving insulin safety also improve patient adherence? If #InsulinTherapy is part of your clinical practice, you won't want to miss this discussion.

👉 Tomorrow at 16:00 CEST: https://t.co/c07KOOkNZi

Supported by an independent medical educational grant from @sanofi.

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Thinking about attending #ATTDASIA26?

Now is the perfect time to secure your place at ATTD-ASIA 2026 and take advantage of the early registration rates.

📍Kyoto, Japan
📅9-11 December 2026
🔗Register now: https://t.co/kobFaBdlwN

#DiabetesTechnology #DiabetesCare

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

🎙️ #ATTDDiabetesTalks: Insulin in Practice
Episode 6️⃣: "Preventing & Managing Hypoglycemia"

🎧 Listen on Spotify: https://t.co/7UhwYwoBv0
🎧 Listen on Apple Podcasts: https://t.co/BdLM4wOYhe

This series is supported by #Sanofi.

#ATTDEducation #ATTDonUNLOK #UNLOKEducation

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

🤩 Two leading voices in #DiabetesTechnology and #DiabetesCare will headline the upcoming #ATTDWebinar on #InsulinTherapy challenges.

📆 Wednesday, June 24 at 16:00 CEST
👉 REGISTER NOW: https://t.co/c07KOOkNZi

Supported by an independent medical educational grant from @sanofi.

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

#ATTDASIA26 には、50か国以上から臨床医、研究者、業界リーダーが集結します。

アジア太平洋地域の糖尿病医療を牽引する人々とつながり、貴社の存在感を高める機会を創出しましょう。

🔗 貴社に最適なパートナーシップについてご相談ください： https://t.co/KcQCiDjpiP

#MedicalConference

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Clinicians, researchers, and industry leaders from 50+ countries meet at #ATTDASIA26.

Network with the people shaping APAC diabetes care. Own visibility moments that put you at the front of the room.

🔗 Explore partnership opportunities: https://t.co/KcQCiDjpiP

#DiabetesinAsia

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

👉 At #ATTD2027, we're looking for groundbreaking research!

📢 Share your work with the global diabetes community and help drive the next wave of innovation.
🔗 Submit your abstract: https://t.co/XUhaCmR6ny

#DiabetesTech #CGM #DigitalHealth

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

⚠️ LAST CALL! Don't miss tomorrow's #ATTDJournalClub on #InhaledInsulin for #Diabetes!

📅 16 June 2026 | 16:00 CEST
👉 SIGN UP BEFORE IT'S TOO LATE: https://t.co/VuznSWzAaC

This online event is supported by #MannKindCorporation.

#ATTDEducation #ATTDonUNLOK #UNLOKEducation

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

🫁Could inhaled insulin impact pulmonary health? Join the live discussion at the #ATTDJournalClub on emerging real-world evidence around inhaled insulin safety. Featuring Dr. Roy Beck, Dr. Todd Burstain & Prof. Irl Hirsch.

📅 16 June 🕖 16:00 CEST

👉 https://t.co/VuznSWzAaC

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Could your innovation be the next to make an impact?

🏆Applications are now open for the #ATTDASIA26 Clinical Innovation Award!
Gain recognition & support for innovations that improve patient outcomes.

🔗https://t.co/2IrqHFMwrz
📅Submission Deadline: 1 September

#DiabetesCare

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

#ATTDASIA26 では、ブースの場所が出会いを左右します。

📍 角地？中央エリア？セッション会場の近く？

50か国以上から集まる900名超の専門家が展示会場を訪れます。人気の出展スペースはすでに選ばれ始めています。

夏前に出展スペースを確保しましょう：https://t.co/tJaQjyXMvr

#DiabetesinAsia

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

📢Applications for the GEMS Participation Grants are open!

Created to support professionals, students, and researchers, the grant offers selected applicants the opportunity to attend ATTD-ASIA 2026 and be part of the latest discussions.

🔗https://t.co/YfCuP1NTyt

#ATTDASIA26